← Leaderboards
Michael A Parniak
Rutgers The St Univ Of Nj New Brunswick
$10,091,941
Attributed
$11,871,167
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–14$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$16,410,271 · 14
By mechanism
U19$7,155,410 · 5
R01$6,767,225 · 4
R33$1,359,600 · 1
P50$545,063 · 1
R21$420,798 · 1
R41$162,175 · 1
Top collaborators
- Stefan G Sarafianos4 shared
- Zhengqiang Wang4 shared
- Rieko Ishima2 shared
Most similar at Rutgers The St Univ Of Nj New Brunswick
Same institution · by research overlap
- Patrick J. Sinko$22,032,586
- Steven J Tuske$118,000
- Daniel M Himmel$154,468
- Roger A Jones$3,327,980
- Stephen E Hughes$0
Others in their field
Top investigators on “Inhibitor/Antagonist”
- John M Lachin · George Washington University$117,867,649
- David M Nathan · Massachusetts Institute Of Technology$117,867,649
- Randall J Bateman · Washington University$110,978,751
- David Heimbrook · Leidos Biomedical Research, Inc.$72,139,282
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Walter John Curran · Thomas Jefferson University$32,790,605
Research focus
Inhibitor/AntagonistAntiviral AgentsPharmaceutical PreparationsPropertyDesignAnalogRibonuclease HHiv InfectionsHiv Drug ResistanceIn VitroCellsDrug ResistancePre-ClinicalStructureResistanceProgramsBaseHiv-1PreventVirusBiochemicalEnzymesComplexLaboratories
Grant awards (45)
Novel antivirals targeting the RNase H activity of HIV reverse transcriptase$748,607
R01 · FY2014 · AI
Project 12$176,968
P50 · FY2014 · GM · contact PI
Novel antivirals targeting the RNase H activity of HIV reverse transcriptase$4,564
R01 · FY2014 · AI
Novel antivirals targeting the RNase H activity of HIV reverse transcriptase$643,710
R01 · FY2013 · AI
Project 12$173,140
P50 · FY2013 · GM · contact PI
Novel antivirals targeting the RNase H activity of HIV reverse transcriptase$710,548
R01 · FY2012 · AI
Microbicide properties of RT inhibitor combinations$439,614
R33 · FY2012 · AI · contact PI
Development of CSIC as a Microbicide$207,460
U19 · FY2012 · AI · contact PI
Project 12$194,955
P50 · FY2012 · GM · contact PI
HIV RNase H natural product inhibitors$897,728
U19 · FY2011 · AI · contact PI
Microbicide properties of RT inhibitor combinations$450,168
R33 · FY2011 · AI · contact PI
HIV RNase H Natural Product Inhibitors: Biochemistry and Virology$276,910
U19 · FY2011 · AI · contact PI
Development of CSIC as a Microbicide$215,943
U19 · FY2011 · AI · contact PI
Administration Core$65,236
U19 · FY2011 · AI · contact PI
HIV RNase H natural product inhibitors$906,793
U19 · FY2010 · AI · contact PI
Microbicide properties of RT inhibitor combinations$469,818
R33 · FY2010 · AI · contact PI
Acylhydrazone inhibitors of HIV-1 ribonuclease H$374,273
R01 · FY2010 · AI · contact PI
HIV RNase H Natural Product Inhibitors: Biochemistry and Virology$276,102
U19 · FY2010 · AI · contact PI
Development of CSIC as a Microbicide$253,742
U19 · FY2010 · AI · contact PI
Administration Core$65,097
U19 · FY2010 · AI · contact PI
HIV RNase H natural product inhibitors$906,157
U19 · FY2009 · AI · contact PI
Acylhydrazone inhibitors of HIV-1 ribonuclease H$374,273
R01 · FY2009 · AI · contact PI
HIV RNase H Natural Product Inhibitors: Biochemistry and Virology$272,334
U19 · FY2009 · AI · contact PI
Development of CSIC as a Microbicide$234,612
U19 · FY2009 · AI · contact PI
Microbicide properties of RT inhibitor combinations$222,852
R21 · FY2009 · AI · contact PI
Administration Core$64,259
U19 · FY2009 · AI · contact PI
HIV RNase H natural product inhibitors$896,645
U19 · FY2008 · AI · contact PI
Bisphosphonate inhibitors of NRTI excision$539,350
R01 · FY2008 · AI · contact PI
HIV RNase H Natural Product Inhibitors: Biochemistry and Virology$268,605
U19 · FY2008 · AI · contact PI
Microbicide properties of RT inhibitor combinations$197,946
R21 · FY2008 · AI · contact PI
Administration Core$62,360
U19 · FY2008 · AI · contact PI
HIV RNase H natural product inhibitors$931,781
U19 · FY2007 · AI · contact PI
Bisphosphonate inhibitors of NRTI excision$543,876
R01 · FY2007 · AI · contact PI
HIV RNase H Natural Product Inhibitors: Biochemistry and Virology$279,274
U19 · FY2007 · AI · contact PI
Administrative Core$74,372
U19 · FY2007 · AI · contact PI
Bisphosphonate inhibitors of NRTI excision$548,355
R01 · FY2006 · AI · contact PI
Chain Terminator Excision in HIV -1 Drug Resistance$288,985
R01 · FY2006 · AI · contact PI
Bisphosphonate inhibitors of NRTI excision$549,851
R01 · FY2005 · AI
Chain Terminator Excision in HIV -1 Drug Resistance$295,971
R01 · FY2005 · AI
Bisphosphonate inhibitors of NRTI excision$563,164
R01 · FY2004 · AI
Chain Terminator Excision in HIV -1 Drug Resistance$296,495
R01 · FY2004 · AI
Chain Terminator Excision in HIV -1 Drug Resistance$285,203
R01 · FY2003 · AI
Mappicine inhibitors of HIV Ribonuclease H$162,175
R41 · FY2003 · AI
Hydrazone inhibitors of HIV Ribonuclease H$0
P01 · FY2002 · GM
Development of NNTRI's as Combination Microbicides$0
U19 · FY2002 · AI